VF
ESPR

Virtu Financial’s Esperion Therapeutics ESPR Stock Holding History

Virtu Financial’s Portfolio ESPR Stock Details ESPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-76,622
Closed -$75K – 1639
2025
Q2 		$75K Buy
76,622
+40,713
+113% +$40.8K ﹤0.01% 1075
2025
Q1 		$52K Sell
35,909
-96,325
-73% -$177K ﹤0.01% 1006
2024
Q4 		$291K Buy
+132,234
New +$309K 0.02% 708
2023
Q4 		– Sell
-181,597
Closed -$178K – 1681
2023
Q3 		$178K Buy
+181,597
New +$263K 0.02% 691
2021
Q3 		– Sell
-13,480
Closed -$285K – 1636
2021
Q2 		$285K Buy
+13,480
New +$325K 0.03% 756
2017
Q4 		– Sell
-12,458
Closed -$624K – 2504
2017
Q3 		$624K Buy
+12,458
New +$601K 0.03% 745

Other funds holding ESPR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
PCM
PenderFund Capital Management Vancouver, British Columbia, Canada $639M AUM 31.05% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return